CYTARABINE, 500 MG/25 ML MULTI-DOSE VIAL U.S. PHYSICIAN PRESCRIBING INFORMATION Description (cytarabine injection)

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional

I am a U.S. Patient / CaregiverNo, go back to the patient portal

Select I am a U.S. Patient / CaregiverNo, go back to the patient portal

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

DESCRIPTION

Cytarabine Injection, an antineoplastic agent, is a sterile preserved solution for intravenous or subcutaneous administration, and is available in a 500 mg (20 mg/mL) multidose vial. Each mL contains: 20 mg Cytarabine, USP and the following inactive ingredients: benzyl alcohol 0.9% and Water for Injection q.s. The pH is adjusted with hydrochloric acid and/or sodium hydroxide to a target pH of 7.6.

Cytarabine is chemically 4-amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone. The structural formula is:

Cytarabine is an odorless, white to off-white, crystalline powder which is freely soluble in water and slightly soluble in alcohol and in chloroform.

Did you find an answer to your question? Yes No

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

CYTARABINE, 500 MG/25 ML MULTI-DOSE VIAL U.S. PHYSICIAN PRESCRIBING INFORMATION Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse reaction, or concern about the quality of a Pfizer product, please call Pfizer at 1-800-438-1985 or visit www.fda.gov/medwatch or call FDA at 1-800-332-1088.
Resources

Download Prescribing Information

Did you find an answer to your question? Yes No

Resources

website

Pfizer RxPathways – find information on prescription assistance programs for eligible patients

Didn’t find what you were looking for? Contact us.

Call 800-438-1985^*

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

Chat^*

*9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch